177Lu-HTK03170
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-HTK03170, covering 2026-01-08 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu-HTK03170 in mCRPC With PSMA Positive Disease [Phase 1, Phase 2]